Health
Results from Phase 0/1 trial of ribociclib plus everolimus in patients with high-grade glioma announced – News-Medical.Net
The Ivy Brain Tumor Center at Barrow Neurological Institute, the largest early-phase drug development program for brain cancer…
The Ivy Brain Tumor Center at Barrow Neurological Institute, the largest early-phase drug development program for brain cancer in the world, announced results from their Phase 0/1 clinical trial of ribociclib plus everolimus in patients with high-grade…
Continue Reading
-
Noosa News24 hours agoAustralia Post reintroduces weekend deliveries for Christmas parcel rush
-
Business21 hours agoWhat I’d buy if I had to invest $20,000 in ASX 200 shares before the weekend
-
Business23 hours agoWhy this investing expert is calling time on NAB shares
-
General19 hours agoFederal government funding extends cohealth GP services until July 2026